{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:40:44Z","timestamp":1761993644147,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.prp.2016.10.004","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T03:14:30Z","timestamp":1476846870000},"page":"1191-1193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Primary cardiac B cell lymphoma: Manifestation of Felty\u2019s syndrome or TNF\u03b1 antagonist"],"prefix":"10.1016","volume":"212","author":[{"given":"Nazim","family":"Benzerdjeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Ameur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fortune","family":"Ikoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Sevestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2016.10.004_bib0005","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"5","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.prp.2016.10.004_bib0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3892\/ol.2013.1779","article-title":"Diagnosis of Felty\u2019s syndrome, distinguished from hematological neoplasm: a case report","volume":"7","author":"Xiao","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2016.10.004_bib0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00002281-200405000-00014","article-title":"Rheumatoid arthritis and malignant lymphomas","volume":"16","author":"Baecklund","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.prp.2016.10.004_bib0020","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2016.10.004_bib0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0828-282X(09)70110-2","article-title":"Primary cardiac diffuse large B cell lymphoma presenting with superior vena cava syndrome","volume":"25","author":"Johri","year":"2009","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.prp.2016.10.004_bib0030","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/modpathol.2009.131","article-title":"Immunomodulator agent-related lymphoproliferative disorders","volume":"22","author":"Hasserjian","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2016.10.004_bib0035","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1097\/PAS.0b013e3180317341","article-title":"Primary cardiac lymphoma: clinical, histologic, immunophenotypic, and genotypic features of 5 cases of a rare disorder","volume":"31","author":"Nascimento","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2016.10.004_bib0040","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/art.11144","article-title":"Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma","volume":"48","author":"Baecklund","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.prp.2016.10.004_bib0045","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","article-title":"Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the food and drug administration","volume":"46","author":"Brown","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.prp.2016.10.004_bib0050","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/ard.2009.117762","article-title":"Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry","volume":"69","author":"Mariette","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.prp.2016.10.004_bib0055","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2008.02029.x","article-title":"Autoimmune and inflammatory disorders and risk of malignant lymphomas\u2013an update","volume":"264","author":"Smedby","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.prp.2016.10.004_bib0060","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3892\/ol.2013.1779","article-title":"Diagnosis of Felty\u2019s syndrome, distinguished from hematological neoplasm: a case report","volume":"7","author":"Xiao","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2016.10.004_bib0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archderm.142.2.198","article-title":"Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors","volume":"142","author":"Deng","year":"2006","journal-title":"Arch. Dermatol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816305350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816305350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T15:37:37Z","timestamp":1568475457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033816305350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0344033816305350"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2016.10.004","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary cardiac B cell lymphoma: Manifestation of Felty\u2019s syndrome or TNF\u03b1 antagonist","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2016.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}